Target intelligence / Profile preview

Transcriptional enhancer factor TEAD1–4 messenger RNA (TEAD1–4 mRNA)

Target
TEAD1–4 mRNA
Molecular classification
Messenger RNA, Transcription factor (encoded protein family)
01

Overview

TEAD1–4 mRNAs are the messenger RNA transcripts encoding the TEA Domain (TEAD) family of transcription factors, which serve as the primary nuclear effectors of the Hippo signaling pathway. In healthy cells, the Hippo pathway regulates organ size and tissue homeostasis by modulating the activity of co-activators YAP and TAZ, which bind to TEAD proteins to drive the expression of genes involved in cell proliferation and survival. In many cancers, particularly those with NF2 mutations or YAP/TAZ overactivation, the TEAD transcription complex becomes constitutively active, driving oncogenesis and drug resistance. Targeting the TEAD1–4 mRNAs using antisense oligonucleotides (ASOs) or RNA interference (RNAi) aims to reduce the cellular pool of TEAD proteins, thereby dismantling the transcriptional machinery required for tumor growth. This approach is currently being explored in clinical settings, with a focus on mesothelioma and other Hippo-deficient solid tumors where TEAD activity is a critical driver.

Other names
TEA domain family member 1–4 mRNATEF-1, TEF-3, TEF-4, and TEF-5 mRNATEAD1/2/3/4 mRNAHippo pathway effector mRNA
02

Mechanism of action

Antisense oligonucleotide-mediated degradation of mRNA, RNA interference (siRNA), inhibition of translation

03

Biological functions

Regulation of transcriptionHippo signaling pathwayCell proliferationApoptosis regulationOrgan size controlEpithelial-mesenchymal transition (EMT)Stem cell maintenance
04

Disease associations

Cancer (specifically Mesothelioma)Solid tumorsHepatocellular carcinomaBreast cancerSquamous cell carcinoma
05

Safety considerations

Liver toxicity (common with ASOs)Renal toxicityPotential impairment of normal tissue regeneration and wound healingOff-target effects on non-cancerous cells utilizing the Hippo pathway
06

Interacting drugs

ION-537 (specifically targets TEAD1 mRNA)

2 more in the full profile.

07

Biomarkers

YAP1 expressionTAZ (WWTR1) expressionNF2 (Merlin) mutation statusLATS1/2 mutation status

Beyond the preview

Go deeper on Transcriptional enhancer factor TEAD1–4 messenger RNA (TEAD1–4 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcriptional enhancer factor TEAD1–4 messenger RNA (TEAD1–4 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call